Sun Pharmaceuticals, Inc., Taro Pharmaceutical Industries Ltd. Company Profile
Established in 1983, listed since 1994 and headquartered in India, Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) is an international, integrated, speciality pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India, U.S. and several other markets across the world. In India, the company is a leader in niche therapy areas of psychiatry, neurology, cardiology, diabetology, gastroenterology, and orthopedics. The company has strong skills in product development, process chemistry, and manufacturing of complex API, as well as dosage forms. More information about the company can be found at www.sunpharma.com.
News Articles
Sun Pharmaceutical Industries Ltd. (BSE:524715; NSE:SUNPHARMA) will acquire the approximately 34% of Taro Pharmaceutical Industries Ltd. (NYSE:TARO) it does not already own for $39.50 per share in cas...
Taro to Announce Results for Year Ended March 31, 2013
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) announced today that it plans to release its financial results for the quarter and year ended March 31, 2013 after ma...
Taro to Announce Third Quarter Results on February 4, 2013
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) announced today that it plans to release its financial results for the quarter and nine months ended December 31, 201...
Taro to Announce Financial Results for the Quarter Ended June 30, 2012
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) announced today that it plans to release its financial results for the quarter ended June 30, 2012 after market close...
Taro to Announce Financial Results for the Quarter Ended September 30, 2012
Taro Pharmaceutical Industries Ltd. (NYSE: TARO) (“Taro”) announced today that it plans to release its financial results for the quarter ended September 30, 2012 after market...
The special committee of the board of directors of Taro Pharmaceutical Industries unanimously rejected the Oct. 18, 2011, unsolicited, non-binding offer from Sun Pharmaceutical Industries—to purchas...
Taro Transition Report For The Three Months Ended March 2012 on Form 20-F Available
Taro Pharmaceutical Industries Ltd. (NYSE: TARO, “Taro”) announced that its Transition Report for the three month period ended March 31, 2012 on Form 20-F, filed with the Secu...
Taro agrees to long-sought acquisition by Sun
Israeli drugmaker Taro Pharmaceutical Industries Ltd. has agreed to a sweetened buyout offer from Sun Pharmaceutical Industries Ltd., paving the way for it to be taken private in a deal that values Ta...
Drugs and Medications
Cetirizine hydrochloride [Taro Pharmaceutical Industries, Ltd.]
Children's Cetirizine Hydrochloride Oral Solution
Clotrimazole [Taro Pharmaceuticals, Inc.]
Clotrimazole Topical Solution USP,1%
Clotrimazole [Taro Pharmaceuticals U.S.A., Inc.]
Clotrimazole Topical Solution USP,1%
Dawnmist hypoallergenic petroleum [Donovan Industries, Inc.]
DawnMist Hypoallergenic Petroleum Jelly
Purell advanced green certified instant hand sanitizer [GOJO Industries, Inc.]
PURELL Advanced Green CertifiedInstant Hand Sanitizer Foam
PubMed Articles
The aim of the study was the production of resistant starch from taro (Colocasia esculenta L. Schott) corm and determination of its effects on health by in vitro methods. Starch was isolated from taro...
Healthy aging: Relationship between quantitative electroencephalogram and cognition.
This study had two goals: (a) to describe the results of the Wechsler Adult Intelligence Scale-III (WAIS-III) and of the quantitative analyses of electroencephalograms (EEG) in elderly adults (60-84 y...
Rapid Estimation of Taro ( Colocasia esculenta ) Quality by Near-Infrared Reflectance Spectroscopy.
The aim of the present study is to develop a methodology for the rapid estimation of taro ( Colocasia esculenta ) quality. Chemical analyses were conducted on 315 accessions for major constituents (st...
Deep Eutectic Solvents (DESs) based upon mixtures of Acrylic Acid (AA) or Methacrylic Acid (MAA) and Choline Chloride (CCl) demonstrated superior performance than regular organic solvents and even ion...
Nanostructure on Taro Leaves Resists Fouling by Colloids and Bacteria under Submerged Conditions.
The antifouling and self-cleaning properties of plants such as Nelumbo nucifera (lotus) and Colocasia esculenta (taro) have been attributed to the superhydrophobicity resulting from the hierarchical s...
Clinical Trials
The primary objectives are to establish the therapeutic equivalence of imiquimod cream 5%, manufactured by Taro Pharmaceuticals Inc. and Aldara (imiquimod) cream, manufactured by 3M, and t...
To demonstrate comparable safety and efficacy of Taro Pharmaceuticals Inc. butenafine hydrochloride cream 1% (test product) and Lotrimin Ultra® cream (reference listed drug) in the treatm...
Pharmacokinetics of Malathion Gel 0.5% and Malathion 0.5% Lotion (Ovide) in Patients With Head Lice
In this study, 24 adult patients with head lice will be treated with a topical malathion head lice treatment; 12 patients will be treated with a novel product, Malathion Gel, 0.5%, and oth...
Brain Neoplasms, Leukemia and Petrochemical Exposures
The aim of this study is to examine the association of exposure to air contaminants (PAH & VOC) emitted from the petrochemical industries, specific genetic polymorphisms (P4501A1 (MspI & e...
Benazepril HCl 40 mg Tablets, Fed
This study will compare the relative bioavailability (rate and extent of absorption) of 40 mg Benazepril Hydrochloride Tablets by TEVA Pharmaceuticals Industries, Ltd. with that of 40 mg L...
Companies
Taro Pharmaceuticals U.S.A., Inc.
Taro entered the U.S. market in 1988, after establishing its Canadian subsidiary in 1984 and receiving approval of its first topical product in the United States.The U.S. has become Taro’s largest m...
Taro Pharmaceutical Industries Ltd.
Taro Pharmaceutical Industries develops, manufactures, and markets high-quality generic and branded pharmaceuticals, both prescription and over-the-counter, used by patients in countries around the wo...
Taro markets a broad range of prescription and over-the-counter products in the United States. We are a leading manufacturer and supplier of topical dermatological products and also have a growing li...
Sun Pharmaceuticals, Inc., Taro Pharmaceutical Industries Ltd.
Established in 1983, listed since 1994 and headquartered in India, Sun Pharmaceutical Industries Ltd. (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) is an international, integr...
On 28. November 2005 the new organisation Federation of Norwegian Industries was established. The new Federation will be formally operative as of 1. January 2006. From the start, the Federation of Nor...
More Information about "Sun Pharmaceuticals, Inc., Taro Pharmaceutical Industries Ltd." on BioPortfolio
We have published hundreds of Sun Pharmaceuticals, Inc., Taro Pharmaceutical Industries Ltd. news stories on BioPortfolio along with dozens of Sun Pharmaceuticals, Inc., Taro Pharmaceutical Industries Ltd. Clinical Trials and PubMed Articles about Sun Pharmaceuticals, Inc., Taro Pharmaceutical Industries Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sun Pharmaceuticals, Inc., Taro Pharmaceutical Industries Ltd. Companies in our database. You can also find out about relevant Sun Pharmaceuticals, Inc., Taro Pharmaceutical Industries Ltd. Drugs and Medications on this site too.
